Week35, 2024
1. National influenza activity remains low, with 0.4% of respiratory specimens testing positive for influenza this week.
2. Of the 147 positive specimens in clinical labs, 85.7% were Influenza A and 14.3% Influenza B; public health labs reported 55 positives, with 96.4% Influenza A and 3.6% Influenza B.
3. Subtype distribution in public health labs includes 61.7% A(H1N1)pdm09 and 38.3% A(H3N2), with no H5 or other novel subtypes detected this week.
4. Outpatient visits for respiratory illness are at 1.8%, below the national baseline, with no jurisdictions reporting moderate or higher activity.
5. Weekly hospitalization rates for influenza are at 0 per 100,000, and cumulative counts show 25,405 total cases this season, 84.6% associated with Influenza A.
6. Deaths attributed to influenza account for 0.06% of reported mortality, with one pediatric death bringing the season's total to 195.
7. Influenza vaccinations continue to be recommended, though no significant vaccination trend updates were noted in this report.
8. No new human infections of novel influenza A viruses were reported this week, though 13 cases of avian influenza A(H5) have been documented this season.
9. Antiviral resistance remains low, with minor cases of reduced susceptibility observed for oseltamivir, peramivir, and baloxavir in specific subtypes.
10. CDC advises ongoing monitoring due to co-circulation of seasonal influenza, COVID-19, and RSV, which may affect future ILI occurrences.